1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
15<br />
Gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects<br />
Diabetes 33(Suppl 3): S 220 – S 224<br />
171. Lynn FC,Pamir N,Ng EH,McIntosh CH,Kieffer TJ,Pederson RA 2001 Defective<br />
glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker<br />
rats. Diabetes 5):1004-1011<br />
172. Tseng CC,Boylan MO,Jarboe LA, Usdin TB, Wolfe MM 1996 Chronic<br />
desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats<br />
Am J Physiol 270:E 661 – E 666<br />
173. El-Quaghlidi A,Holle H,Nauck NA 2005 Tachyphylaxis is not the cause for<br />
reduced insulinotropic action of gastric inhibitory polypeptide(GIP) in type 2 diabetes<br />
Diabetologia 48(Suppl 1):A-547<br />
174. Miholic J,Orskov O,Holst JJ,Kotzerke J, Meyer HJ 1991 Emptying of the gastric<br />
substitute,glucagon-like peptide-l(GLP-1) and reactive hypoglycemia after total<br />
gastrectomy Dig Dis Sci 36:1361-1370<br />
175. Qualmann,Nauck MA,Holst JJ,Orskov O,Creutzfeldt W 1995 Glucagon-like peptide<br />
1(7-36 amide) secretion in response to luminal sucrose from upper and lower gut. A study<br />
using α-glucosidase inhibition Scand J Gastroenterol 30:892-896<br />
176. Creutzfeldt WO,Kleine N,Willms B,Orskov C,Holst JJ,Nauck MA 1996<br />
Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagonlike<br />
peptide 1 (7-36)amide in type 1 diabetic patients. Diabetes Care 19:580-586<br />
177. Dupré J 2005 Glycaemic effects of incretins in type 1 diabetes mellitus.A<br />
concise review,with emphasis on studies in humans .Regul Pept 128:149-157<br />
178. Dupré J,Behme MT,McDonald TJ 2004 Exendin-4 normalized post cibal glycemic<br />
excursions in type 1 diabetes. J Clin Endocrinol Metab 89:3469-3473<br />
179. Jones- Leone A,Yu T,Barilla D,He L-Y,Ho YY,Ligueros-Saylan M,Foley J,Kelly D<br />
2004 Evidence for insulin independent suppression of glucagon secretion by LAF237.<br />
Diabetologia 47(Suppl 1):A289<br />
180. Quddusi S,Vahl TP,Hanson K,Prigeon RL, D `Alessio DA 2003 Differential effects<br />
of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase<br />
insulin secretion in diabetic and non-diabetic humans Diabetes Care 26:791-798<br />
181. Byrne MM , Gliem K,Wank U,Arnold R, Katschinski M ,Polonsky KS, Göeke B<br />
1998 Glucagon-like peptide 1 improves the ability of the β-cell to sense and responde to<br />
glucose in subjects with impaired glucose tolerance Diabetes 47:1259-1265<br />
182. Drucker DJ 2003 Glucagon-like peptides :Regulators of cell<br />
proliferation,differentiation ,and apoptosis. Mol Endocrinol 17: 161-171